tirzepatide discontinuation for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Potential Maintenance Off-Ramp Showing Promise

375, n o 4, 311322 (ISSN 0028-4793 et 1533-4406, DOI 10.1056/NEJMoa1603827, lire en ligne, consult le Knut Dahl-Jrgensen, Near-normoglycemia and late diabetic complications , Acta Endocrinologica , vol

With ongoing studies exploring its use in other conditions, such as cardiovascular disease, this drug could change the way we approach metabolic diseases in the future

PMC 434288

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Understanding thyroid nodules before evaluating medication risk Before diving into tirzepatide safety data, you need context about what thyroid nodules actually are